Title not available
Abstract
Translate Article 
Take Notes
More from: Clinical and Experimental NeuroimmunologyReply to “Reply to Seroconversion After SARS ‐ CoV ‐2 Vaccination in B‐Cell‐Depleted Patients: The Missing Factors” An Adult Case of Severe, Refractory, and Progressive Leukodystrophy‐Like Diffuse Encephalitis With MOG ‐ IgG Treated With Rituximab Issue Information Heterogeneity of Ocular Myasthenia Gravis: Potential Subgroups Reply to “Seroconversion After SARS‐CoV‐2 Vaccination in B‐Cell‐Depleted Patients: The Missing Factors” NMOSD : Adaptive Immunity Revisited Seroconversion After SARS ‐ CoV ‐2 Vaccination in B‐Cell‐Depleted Patients: The Missing Factors Neuromyelitis Optica Spectrum Disorder: Clinical Features and Treatments Revisited NMOSD Revisited
- Research Article
- 10.1111/cen3.70036
- Nov 5, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.70035
- Nov 3, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.12800
- Nov 1, 2025
- Clinical and Experimental Neuroimmunology
- Journal Issue
- 10.1111/cen3.v16.4
- Nov 1, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.70034
- Oct 26, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.70031
- Oct 6, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.70030
- Oct 3, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.70028
- Oct 1, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.70029
- Sep 30, 2025
- Clinical and Experimental Neuroimmunology
- Research Article
- 10.1111/cen3.70025
- Sep 18, 2025
- Clinical and Experimental Neuroimmunology
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.